The Commission released the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard on 9 May 2024. It provides guidance to clinicians, healthcare services and consumers on the safe and appropriate use of psychotropic medicines.
A consumer guide on healthcare rights was developed to support the safety and quality of health care for people with cognitive impairment.
The consumer guide is available in Easy English and several languages here.
The Commission has developed resources to support implementation of the 2nd edition of the NSQHS Standards:
